Concentrix (NASDAQ:CNXC) Stock

Concentrix

CNX Coal Resources

Concentrix Corp is a technology enabled company specialized in customer engagement and customer management. The company provides end-to-end capabilities, including CX process optimization, technology innovation and design engineering, front- and back-office automation, analytics and business transformation services to clients in five industry verticals. The Company's verticals are technology and consumer electronics, retail, travel and e-commerce, communications and media, banking, financial services and insurance, and healthcare. Geographically, the company operates in Philippines, Unites States, India, Frances and Others. Maximum revenue is from Technology and consumer electronics industry and geographically from USA.

Couple Charged In $1 Million Lululemon Shoplifting Ring

News

Price Target

Markets

Analyst Ratings

Trading Ideas

CBRL

CNXC

DXCM

LULU

STNE

Lululemon To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Thursday

Analysts

Earnings

Top Wall Street Forecasters Revamp Concentrix Price Expectations Ahead Of Q4 Earnings

Dividend Yield

Dividends

Pre-Market Outlook

CMRE

Wall Street&#39;s Most Accurate Analysts Give Their Take On 3 Industrials Stocks With Over 3% Dividend Yields

Concentrix Corp

In the current market session, Concentrix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) share price is at $50.11, after a 4.15% drop. Over the past month, the stock spiked by 8.20%, but over the past year, it actually decreased by 42.54%. With good short-term performance like this, and questionable long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio.

<img src="https://www.benzinga.com/files/images/story/2025/1738615511_0.png" alt="Past Year Chart" />

<h3>How Does Concentrix P/E Compare to Other Companies?</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 25.05 in the Professional Services industry, Concentrix Inc. has a lower P/E ratio of 14.09. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1738615511_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

P/E Ratio Insights for Concentrix

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>JP Morgan cut the price target for The Procter &amp; Gamble Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) from $186 to $181. JP Morgan analyst Andrea Teixeira maintained an Overweight rating. Procter &amp; Gamble shares closed at $159.65 on Wednesday. <a href="https://www.benzinga.com/quote/PG/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
<ul>
<li>Canaccord Genuity slashed Concentrix Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NYSE">CNXC</a>) price target from $100 to $80. Canaccord Genuity analyst Joseph Vafi maintained a Buy rating. Concentrix shares closed at $47.47 on Wednesday. <a href="https://www.benzinga.com/quote/CNXC/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan cut the price target for The Hershey Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HSY#NYSE">HSY</a>) from $171 to $151. JP Morgan analyst Ken Goldman maintained a Neutral rating. Hershey shares closed at $155.31 on Wednesday. <a href="https://www.benzinga.com/quote/HSY/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Truist Securities increased the price target for Cracker Barrel Old Country Store, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBRL#NASDAQ">CBRL</a>) from $48 to $51. Truist Securities analyst Jake Bartlett maintained a Hold rating. Cracker Barrel shares closed at $57.57 on Wednesday. <a href="https://www.benzinga.com/quote/CBRL/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Baird raised DexCom, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXCM#NASDAQ">DXCM</a>) price target from $86 to $104. Baird analyst Jeff Johnson upgraded the stock from Neutral to Outperform. DexCom shares settled at $80.40 on Wednesday. <a href="https://www.benzinga.com/quote/DXCM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Deutsche Bank raised The Bank of New York Mellon Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BK#NYSE">BK</a>) price target from $94 to $98. Deutsche Bank analyst Brian Bedell maintained a Buy rating. Bank of New York Mellon shares closed at $82.04 on Wednesday. <a href="https://www.benzinga.com/quote/BK/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Citigroup slashed StoneCo Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STNE#NASDAQ">STNE</a>) price target from $19 to $9. Citigroup analyst Gustavo Schroden downgraded the stock from Buy to Neutral. StoneCo shares closed at $8.74 on Wednesday.  <a href="https://www.benzinga.com/quote/STNE/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan raised the price target for Lululemon Athletica Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) from $428 to $437. JP Morgan analyst Matthew Boss maintained an Overweight rating. Lululemon shares settled at $376.66 on Wednesday. <a href="https://www.benzinga.com/quote/LULU/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Northland Capital Markets raised Vitesse Energy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTS#NYSE">VTS</a>) price target from $28 to $31. Northland Capital Markets analyst Bobby Brooks maintained an Outperform rating. Vitesse Energy shares closed at $27.12 on Wednesday. <a href="https://www.benzinga.com/quote/VTS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan raised The Goldman Sachs Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) price target from $550 to $605. JP Morgan analyst Kian Abouhossein maintained an Overweight rating. Goldman Sachs shares closed at $605.92 on Wednesday. <a href="https://www.benzinga.com/quote/GS/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/01/43026927/how-to-earn-500-a-month-from-j-b-hunt-transport-stock-ahead-of-q4-earnings">How To Earn $500 A Month From J.B. Hunt Transport Stock Ahead Of Q4 Earnings</a></li>
</ul>

Canaccord Genuity analyst Joseph Vafi maintains Concentrix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) with a Buy and lowers the price target from $100 to $80.

Canaccord Genuity Maintains Buy on Concentrix, Lowers Price Target to $80

Concentrix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) reported its Q4 earnings results on Wednesday, January 15, 2025 at 04:05 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Concentrix beat estimated earnings by 8.0%, reporting an EPS of $3.26 versus an estimate of $3.01.
Revenue was up $217.00 million from the same period last year.
<h3>Analysis of Past Earnings</h3>
In the previous quarter, the company missed on EPS by $0.06, resulting in a 19.0% drop change in the share price the following day.
Here's a look at Concentrix's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>2.93</td>
<td>2.62</td>
<td>2.58</td>
<td>3.08</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>2.87</td>
<td>2.69</td>
<td>2.57</td>
<td>3.36</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>2.38B</td>
<td>2.35B</td>
<td>2.38B</td>
<td>2.20B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>2.39B</td>
<td>2.38B</td>
<td>2.40B</td>
<td>2.23B</td>
</tr>
</tbody>
</table>

To track all earnings releases for Concentrix <a href="https://www.benzinga.com/quote/CNXC/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Concentrix: Q4 Earnings Insights

WIIM

Concentrix shares are trading lower following soft guidance.

Guidance

Concentrix Sees Q1 Non-GAAP EPS $2.49-$2.64 vs $2.85 Est., Revenue $2.355B-$2.370B vs $2.409B Est.; Sees FY25 Non-GAAP EPS $11.18-$11.77 vs $11.97 Est., Revenue $9.470B-$9.610B vs $9.726B Est.

Buybacks

Concentrix Increases Share Repurchase Authorization To $600M

Concentrix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) reported quarterly earnings of $3.26 per share which beat the analyst consensus estimate of $3.01 by 8.31 percent. The company reported quarterly sales of $2.448 billion which beat the analyst consensus estimate of $2.441 billion by 0.30 percent. This is a 9.73 percent increase over sales of $2.231 billion the same period last year.

Earnings Beats

Concentrix Q4 2024 Adj. EPS $3.26 Beats $3.01 Estimate, Sales $2.448B Beat $2.441B Estimate

<h3>Companies Reporting Before The Bell</h3>
• BlackRock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) is likely to report quarterly earnings at $11.21 per share on revenue of $5.53 billion. 
• Valens Semiconductor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLN#NYSE">VLN</a>) is likely to report earnings for its third quarter. 
• JPMorgan Chase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) is likely to report quarterly earnings at $4.04 per share on revenue of $41.56 billion. 
• Goldman Sachs Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) is estimated to report quarterly earnings at $8.27 per share on revenue of $12.33 billion. 
• Citigroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>) is expected to report quarterly earnings at $1.24 per share on revenue of $19.41 billion. 
• Bank of New York Mellon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BK#NYSE">BK</a>) is projected to report quarterly earnings at $1.54 per share on revenue of $4.63 billion. 
• Wells Fargo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>) is projected to report quarterly earnings at $1.26 per share on revenue of $20.28 billion. 
<h3>Companies Reporting After The Bell</h3>
• Home BancShares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HOMB#NYSE">HOMB</a>) is expected to report quarterly earnings at $0.52 per share on revenue of $256.67 million. 
• Synovus Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNV#NYSE">SNV</a>) is likely to report quarterly earnings at $1.15 per share on revenue of $566.76 million. 
• H.B. Fuller (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUL#NYSE">FUL</a>) is projected to report quarterly earnings at $0.92 per share on revenue of $904.32 million. 
• Concentrix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) is likely to report quarterly earnings at $3.07 per share on revenue of $2.44 billion. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

HOMB

Earnings Scheduled For January 15, 2025

Concentrix Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NYSE">CNXC</a>) will release its fourth-quarter financial results after the<a href="https://www.benzinga.com/quote/CNXC/earnings"> closing bell on Wednesday, Jan. 15.</a>
Analysts expect the Newark, California-based company to report quarterly earnings at $3.01 per share, down from $3.36 per share in the year-ago period. Concentrix projects quarterly revenue of $2.44 billion, compared to $2.23 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Sept. 25, Concentrix reported quarterly earnings of $2.87 per share, which missed the analyst consensus estimate of $2.93 per share.
Concentrix shares fell 0.4% to close at $45.60 on Wednesday&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; .
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/CNXC/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Baird analyst David Koning initiated coverage on the stock with an Outperform rating and a price target of $70 on Oct. 3, 2024. This analyst has an accuracy rate of 79%.</li>
<li>Barrington Research analyst Vincent Colicchio maintained an Outperform rating and cut the price target from $84 to $70 on Sept. 26, 2024. This analyst has an accuracy rate of 61%.</li>
<li>Canaccord Genuity analyst Joseph Vafi maintained a Buy rating and cut the price target from $125 to $100 on Sept. 26, 2024. This analyst has an accuracy rate of 80%.</li>
</ul>
Considering buying CNXC stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="594" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/09123810/image-53-1024x594.png" alt="" class="wp-image-726577" style="width:564px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/09123810/image-53-1024x594.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/09123810/image-53-300x174.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/09123810/image-53-768x446.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/09123810/image-53.png 1117w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/01/42873668/jim-cramer-lemonade-is-up-too-much-this-health-care-stock-can-go-lower">Jim Cramer: Lemonade Is &#8216;Up Too Much,&#8217; This Health Care Stock Can Go Lower (UPDATED)</a></li>
</ul>

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the industrials sector.
<h3 class="wp-block-heading">Concentrix Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>)</h3>
<ul>
<li>Dividend Yield: 3.15%</li>
<li>Baird analyst David Koning initiated coverage on the stock with an Outperform rating and a price target of $70 on Oct. 3. This analyst has an accuracy rate of 79%.</li>
<li>Barrington Research analyst Vincent Colicchio maintained an Outperform rating and cut the price target from $84 to $70 on Sept. 26. This analyst has an accuracy rate of 62%.</li>
<li>Recent News: On Sept. 25, Concentrix reported quarterly earnings of $2.87 per share, which missed the analyst consensus estimate of $2.93 per share.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121824&amp;t=be2bearmibe3na1">latest CNXC news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="901" height="830" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18092036/image-154.png" alt="" class="wp-image-697785" style="width:586px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18092036/image-154.png 901w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18092036/image-154-300x276.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18092036/image-154-768x707.png 768w" sizes="(max-width: 901px) 100vw, 901px" /></a></figure>
<h3 class="wp-block-heading">Costamare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMRE#NYSE">CMRE</a>)</h3>
<ul>
<li>Dividend Yield: 3.64%</li>
<li>Jefferies analyst Omar Nokta maintained a Hold rating with a price target of $13 on Nov. 1. This analyst has an accuracy rate of 60%.</li>
<li>Stifel analyst Benjamin Nolan maintained a Hold rating and raised the price target from $12 to $14 on July 24. This analyst has an accuracy rate of 69%.</li>
<li>Recent News: On Nov. 1, Costamare posted better-than-expected quarterly earnings.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121824&amp;t=be2bearmibe3na1">latest CMRE news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="902" height="838" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18092307/image-155.png" alt="" class="wp-image-697797" style="width:689px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18092307/image-155.png 902w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18092307/image-155-300x279.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18092307/image-155-768x714.png 768w" sizes="(max-width: 902px) 100vw, 902px" /></a></figure>
<h3 class="wp-block-heading">Stanley Black &amp; Decker, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SWK#NYSE">SWK</a>)</h3>
<ul>
<li>Dividend Yield: 3.99%</li>
<li>Morgan Stanley analyst Chris Snyder maintained an Equal-Weight rating and cut the price target from $107 to $98 on Oct. 30. This analyst has an accuracy rate of 72%.</li>
<li>Wells Fargo analyst Joseph O'Dea maintained an Equal-Weight rating and lowered the price target from $104 to $100 on Oct. 30. This analyst has an accuracy rate of 62%.</li>
<li>Recent News: On Nov. 20, Stanley Black &amp; Decker issued a strategic update, reaffirming its FY24 earnings guidance of $3.90-$4.30 per share.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121824&amp;t=be2bearmibe3na1">trend in SWK stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="925" height="847" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18092325/image-156.png" alt="" class="wp-image-697798" style="width:672px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18092325/image-156.png 925w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18092325/image-156-300x275.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18092325/image-156-768x703.png 768w" sizes="(max-width: 925px) 100vw, 925px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42551008/top-3-health-care-stocks-that-may-explode-in-q4">Top 3 Health Care Stocks That May Explode In Q4</a></li>
</ul>

Wall Street's Most Accurate Analysts Give Their Take On 3 Industrials Stocks With Over 3% Dividend Yields

The most oversold stocks in the industrials sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Rentokil Initial plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTO#NYSE">RTO</a>)</h3>
<ul>
<li>On Sept. 11, Rentokil Initial revised the guidance for the second half of FY24. The company projects organic revenue growth for North America operations to be about 1% in the second half of 2024, with operating profit anticipated to be impacted by higher sales, service, and other costs. The company's stock fell around 25% over the past month and has a <a href="https://www.benzinga.com/quote/RTO">52-week low of $23.39</a>.</li>
<li>RSI Value: 29.83</li>
<li>RTO Price Action: Shares of Rentokil Initial fell 0.6% to close at $23.55 on Tuesday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent100924&amp;t=be2bearmibe3na1">latest RTO news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent100924&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="907" height="847" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/09063801/image-56.png" alt="" class="wp-image-587289" style="width:726px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/09063801/image-56.png 907w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/09063801/image-56-300x280.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/09063801/image-56-768x717.png 768w" sizes="(max-width: 907px) 100vw, 907px" /></a></figure>
<h3 class="wp-block-heading">Blue Bird Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLBD#NASDAQ">BLBD</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>On Oct. 3, Roth MKM analyst Craig Irwin downgraded Blue Bird from Buy to Neutral and maintained the price target of $48. The company's stock fell around 10% over the past five days. It <a href="https://www.benzinga.com/quote/BLBD">has a 52-week low</a> of $17.60.</li>
<li>RSI Value: 27.62</li>
<li>BLBD Price Action: Shares of Blue Bird fell 1.8% to close at $41.28 on Tuesday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent100924&amp;t=be2bearmibe3na1">trend in BLBD stock</a>. </li>
</ul>
<figure class="wp-block-image is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent100924&amp;t=be2bearmibe3na1"><img decoding="async" src="blob:https://editorial.benzinga.com/8d1535b6-9ac9-4100-90d5-ea90400c8d40" alt="" style="width:688px;height:auto" /></a></figure>
<h3 class="wp-block-heading">Concentrix Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>)</h3>
<ul>
<li>On Oct. 3, Baird analyst David Koning initiated coverage on Concentrix with an Outperform rating and announced a price target of $70. The company's shares fell around 32% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/CNXC">low of $48.71</a>.</li>
<li>RSI Value: 17.33</li>
<li>CNXC Price Action: Shares of Concentrix fell 5.6% to close at $48.74 on Tuesday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent100924&amp;t=be2bearmibe3na1">breakout in CNXC shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent100924&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="892" height="847" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/09063944/image-58.png" alt="" class="wp-image-587298" style="width:636px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/09063944/image-58.png 892w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/09063944/image-58-300x285.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/09063944/image-58-768x729.png 768w" sizes="(max-width: 892px) 100vw, 892px" /></a></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/10/41238686/jim-cramer-ast-spacemobile-is-just-too-hot-recommends-buying-this-tech-stock">Jim Cramer: AST SpaceMobile Is &#8216;Just Too Hot,&#8217; Recommends Buying This Tech Stock</a></li>
</ul>

Long Ideas

BLBD

Top 3 Industrials Stocks Which Could Blast Off This Quarter

Baird analyst David Koning initiates coverage on Concentrix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) with a Outperform rating and announces Price Target of $70.

Initiation

Baird Initiates Coverage On Concentrix with Outperform Rating, Announces Price Target of $70

U.S. stocks traded higher toward the end of trading, with the Dow Jones index rising more than 250 points on Thursday.
The Dow traded up 0.63% to 42,177.28 while the NASDAQ rose 0.54% to 18,179.88. The S&amp;P 500 also rose, gaining, 0.36% to 5,743.03.
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/09/41045161/how-to-earn-500-a-month-from-costco-stock-ahead-of-q4-earnings">How To Earn $500 A Month From Costco Stock Ahead Of Q4 Earnings</a>
Leading and Lagging Sectors Materials shares jumped by 1.9% on Thursday.
In trading on Thursday, energy shares fell by 2%.
Top Headline
Accenture Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>) reported better-than-expected earnings for its fourth quarter.
The company posted quarterly sales of $16.41 billion compared with the analyst consensus estimate of $16.39 billion, up 3% Y/Y in U.S. dollars and 5% in local currency. The adjusted EPS of $2.79 topped the analyst consensus estimate of $2.77.
Accenture declared a quarterly cash dividend of $1.48 per share, implying a growth of 15%. The board approved $4.0 billion in additional share repurchase authority, bringing Accenture's total outstanding authority to approximately $6.7 billion.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Telesis Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBIO#NASDAQ">TBIO</a>) shares shot up 43% to $3.31 after the company announced a partnership with Beckman Coulter Life Sciences to revolutionize DNA and mRNA synthesis.</li>
<li>Shares of Pasithea Therapeutics Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTTA#NASDAQ">KTTA</a>) got a boost, surging 62% to $6.24 after the company announced safety, tolerability, pharmacokinetic and preliminary efficacy data from the first 2 cohorts of patients in its Phase 1 clinical trial of PAS-004.</li>
<li>Jabil Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JBL#NYSE">JBL</a>) shares were also up, gaining 11% to $125.56 after the company reported better-than-expected fourth-quarter financial results and approved a $1 billion share buyback.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Concentrix Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) shares dropped 16% to $53.29 following mixed third-quarter financial results.</li>
<li>Shares of Ryde Group Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYDE#NYSE">RYDE</a>) were down 32% to $0.7792 after the company announced a $4.5 million public offering at $0.85 per unit.</li>
<li>MDxHealth SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDXH#NASDAQ">MDXH</a>) was down, falling 21% to $2.00 after the company announced the pricing of a $40 million offering of 20 million shares at $2.00 per share</li>
</ul>
Commodities In commodity news, oil traded down 2.5% to $67.95 while gold traded up 0.2% at $2,690.70.
Silver traded up 0.9% to $32.315 on Thursday, while copper rose 3.1% to $4.6290.
Euro zone
European shares closed higher today. The eurozone's STOXX 600 gained 1.25%, Germany's DAX climbed 1.69% and France's CAC 40 jumped 2.33%. Spain's IBEX 35 Index rose 1.36%, while London's FTSE 100 rose 0.20%.
Bank lending to households in the Eurozone increased by 0.6% year-over-year to €6.891 trillion in August compared to a 0.5% rise in the prior month. The GfK Consumer Climate Indicator for Germany climbed to a reading of -21.2 heading into October versus a revised reading of -21.9 in the prior period.
Asia Pacific Markets
Asian markets closed mostly higher on Thursday, with Japan's Nikkei 225 jumping 2.79%, Hong Kong's Hang Seng Index jumping 4.16%, China's Shanghai Composite Index gaining 3.61% and India's BSE Sensex gaining 0.78%.
Hong Kong&#8217;s trade deficit widened to $33.1 billion in August versus $25.6 billion in the year-ago month.
Economics
<ul>
<li>U.S. core PCE prices increased by 2.8% from the prior quarter during the second quarter compared to a 3.7% gain in the previous period.</li>
<li>U.S. durable goods orders came in mostly unchanged from the previous month in August versus the revised 9.8% jump in the earlier period.</li>
<li>U.S. initial jobless claims fell by 4,000 from the prior week to 218,000 during the period ending September 21, compared to estimates of 225,000.</li>
<li>The US economy expanded at an annualized rate of 3% during the second quarter versus a revised 1.6% increase in the first quarter.</li>
<li>Pending home sales in the U.S. rose by 0.6% from the prior month in August versus market estimates of a 0.3% increase.</li>
<li>U.S. natural-gas stocks rose 47 billion cubic feet in the week ended Sept. 20, compared to market estimates of a 52 bcf gain.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/09/41045737/top-3-materials-stocks-youll-regret-missing-this-quarter">Top 3 Materials Stocks You&#8217;ll Regret Missing This Quarter</a></li>
</ul>

Equities

Eurozone

Commodities

KTTA

MDXH

RYDE

TBIO

Dow Surges Over 250 Points; Accenture Earnings Top Views

<h3>Gainers</h3>
<ul>
<li>Multi Ways Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MWG#AMEX">MWG</a>) shares increased by 28.8% to $0.56 during Thursday's regular session. The market value of their outstanding shares is at $18.3 million. </li>
<li>BlackSky Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKSY#NYSE">BKSY</a>) shares increased by 16.5% to $4.73. The company's market cap stands at $88.0 million. </li>
<li>Laser Photonics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LASE#NASDAQ">LASE</a>) stock increased by 14.23% to $13.59. The company's market cap stands at $166.4 million. </li>
<li>Nano Nuclear Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNE#NASDAQ">NNE</a>) stock moved upwards by 14.0% to $14.41. The company's market cap stands at $434.1 million. </li>
<li>SOS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOS#NYSE">SOS</a>) shares moved upwards by 13.18% to $0.83. The company's market cap stands at $16.4 million. The company's, H1 earnings came out 2 days ago. </li>
<li>Azul (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZUL#NYSE">AZUL</a>) stock moved upwards by 12.86% to $3.12. The company's market cap stands at $361.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Ryde Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/RYDE#AMEX">RYDE</a>) shares fell 32.3% to $0.78 during Thursday's regular session. The market value of their outstanding shares is at $16.3 million. </li>
<li>Expion360 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XPON#NASDAQ">XPON</a>) shares declined by 21.55% to $0.07. The market value of their outstanding shares is at $3.6 million. </li>
<li>Concentrix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) shares decreased by 15.86% to $53.53. The company's market cap stands at $3.4 billion. As per the press release, Q3 earnings came out yesterday. </li>
<li>XCHG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCH#NASDAQ">XCH</a>) shares declined by 14.71% to $9.86. The company's market cap stands at $584.9 million. </li>
<li>Shimmick (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHIM#NASDAQ">SHIM</a>) stock declined by 9.1% to $2.3. The market value of their outstanding shares is at $77.2 million. </li>
<li>Falcons Beyond Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FBYD#NASDAQ">FBYD</a>) shares declined by 8.36% to $9.42. The market value of their outstanding shares is at $108.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

AZUL

BlackSky Technology Inc. Class A Common Stock

BKSY

FBYD

LASE

SHIM

XPON

12 Industrials Stocks Moving In Thursday's Intraday Session

B of A Securities analyst Ruplu Bhattacharya maintains Concentrix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) with a Neutral and lowers the price target from $85 to $70.

B of A Securities Maintains Neutral on Concentrix, Lowers Price Target to $70

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 200 points on Thursday.
The Dow traded up 0.47% to 42,110.56 while the NASDAQ rose 0.19% to 18,117.40. The S&amp;P 500 also rose, gaining, 0.21% to 5,734.09.
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/09/41045161/how-to-earn-500-a-month-from-costco-stock-ahead-of-q4-earnings">How To Earn $500 A Month From Costco Stock Ahead Of Q4 Earnings</a>
Leading and Lagging Sectors Materials shares jumped by 1.8% on Thursday.
In trading on Thursday, energy shares fell by 1.9%.
Top Headline
U.S. initial jobless claims fell by 4,000 from the prior week to 218,000 during the period ending September 21, compared to estimates of 225,000.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Telesis Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBIO#NASDAQ">TBIO</a>) shares shot up 71% to $3.96 after the company announced a partnership with Beckman Coulter Life Sciences to revolutionize DNA and mRNA synthesis.</li>
<li>Shares of Pasithea Therapeutics Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTTA#NASDAQ">KTTA</a>) got a boost, surging 66% to $6.37 after the company announced safety, tolerability, pharmacokinetic and preliminary efficacy data from the first 2 cohorts of patients in its Phase 1 clinical trial of PAS-004.</li>
<li>Adaptive Biotechnologies Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADPT#NASDAQ">ADPT</a>) shares were also up, gaining 25% to $5.00.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Concentrix Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) shares dropped 16% to $53.65 following mixed third-quarter financial results.</li>
<li>Shares of Ryde Group Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYDE#NYSE">RYDE</a>) were down 30% to $0.81 after the company announced a $4.5 million public offering at $0.85 per unit.</li>
<li>MDxHealth SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDXH#NASDAQ">MDXH</a>) was down, falling 21% to $2.00 after the company announced the pricing of a $40 million offering of 20 million shares at $2.00 per share</li>
</ul>
Commodities In commodity news, oil traded down 2.4% to $68.00 while gold traded up 0.2% at $2,688.80.
Silver traded up 1.3% to $32.435 on Thursday, while copper rose 2.9% to $4.6195.
Euro zone
European shares were higher today. The eurozone's STOXX 600 gained 1.13%, Germany's DAX climbed 1.52% and France's CAC 40 jumped 2.08%. Spain's IBEX 35 Index rose 1.39%, while London's FTSE 100 rose 0.12%.
Bank lending to households in the Eurozone increased by 0.6% year-over-year to €6.891 trillion in August compared to a 0.5% rise in the prior month. The GfK Consumer Climate Indicator for Germany climbed to a reading of -21.2 heading into October versus a revised reading of -21.9 in the prior period.
Asia Pacific Markets
Asian markets closed mostly higher on Thursday, with Japan's Nikkei 225 jumping 2.79%, Hong Kong's Hang Seng Index jumping 4.16%, China's Shanghai Composite Index gaining 3.61% and India's BSE Sensex gaining 0.78%.
Hong Kong&#8217;s trade deficit widened to $33.1 billion in August versus $25.6 billion in the year-ago month.
Economics
<ul>
<li>U.S. core PCE prices increased by 2.8% from the prior quarter during the second quarter compared to a 3.7% gain in the previous period.</li>
<li>U.S. durable goods orders came in mostly unchanged from the previous month in August versus the revised 9.8% jump in the earlier period.</li>
<li>U.S. initial jobless claims fell by 4,000 from the prior week to 218,000 during the period ending September 21, compared to estimates of 225,000.</li>
<li>The US economy expanded at an annualized rate of 3% during the second quarter versus a revised 1.6% increase in the first quarter.</li>
<li>Pending home sales in the U.S. rose by 0.6% from the prior month in August versus market estimates of a 0.3% increase.</li>
<li>U.S. natural-gas stocks rose 47 billion cubic feet in the week ended Sept. 20, compared to market estimates of a 52 bcf gain.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/09/41045737/top-3-materials-stocks-youll-regret-missing-this-quarter">Top 3 Materials Stocks You&#8217;ll Regret Missing This Quarter</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

ADPT

Crude Oil Down Over 2%; US Initial Jobless Claims Fall

Barrington Research analyst Vincent Colicchio maintains Concentrix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) with a Outperform and lowers the price target from $84 to $70.

Barrington Research Maintains Outperform on Concentrix, Lowers Price Target to $70

Canaccord Genuity analyst Joseph Vafi maintains Concentrix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) with a Buy and lowers the price target from $125 to $100.

Canaccord Genuity Maintains Buy on Concentrix, Lowers Price Target to $100

U.S. stock futures were higher this morning, with the Dow futures gaining around 200 points on Thursday.
Shares of Concentrix Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) fell sharply in today's pre-market trading following mixed <a href="https://www.benzinga.com/news/earnings/24/09/41035576/concentrix-stock-falls-after-mixed-q3-results-ix-hello-genai-launch-annoucement">third-quarter financial results.</a>
Concentrix reported quarterly earnings of $2.87 per share, which missed the analyst consensus estimate of $2.93 per share. Quarterly revenue came in at $2.387 billion, which beat the analyst consensus estimate of $2.382 billion.
Concentrix shares dipped 13.8% to $54.79 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>One Liberty Properties, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLP#NYSE">OLP</a>) shares dipped 26.3% to $20.02 in pre-market trading.</li>
<li>Pagaya Technologies Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGY#NASDAQ">PGY</a>) shares fell 15% to $10.59 in pre-market trading after the company announced its intention to offer $125 million of exchangeable senior notes due 2029 in a private offering.</li>
<li>Critical Metals Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRML#NASDAQ">CRML</a>) shares declined 8.3% to $6.00 in pre-market trading after dipping over 8% on Wednesday.</li>
<li>CarMax, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMX#NYSE">KMX</a>) shares declined 7.3% to $69.02 in pre-market trading following downbeat quarterly earnings.</li>
<li>Armada Hoffler Properties, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AHH#NYSE">AHH</a>) declined 7.3% to $11.00 in pre-market trading. Armada Hoffler announced upsizing and pricing of public offering of common stock.</li>
<li>Sonos, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONO#NASDAQ">SONO</a>) shares fell 6% to $11.86 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/09/41024505/top-5-industrials-stocks-that-may-collapse-in-q3">Top 5 Industrials Stocks That May Collapse In Q3</a></li>
</ul>

CRML

SONO

Concentrix Reports Weak Earnings, Joins CarMax And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Press Releases

Concentrix Reports Second Quarter 2024 Results

Concentrix Sets Bold Goals to Support People and Planet in New Sustainability Report

Concentrix Schedules Release of Third Quarter 2024 Financial Results and Webcast of Investor Conference Call

Concentrix Reports Third Quarter 2024 Results

General

Concentrix Introduces Intelligent Experience Technology Product Suite with Launch of iX Hello™

Concentrix to share new insights on AI and intelligent experiences at Web Summit 2024

Concentrix Schedules Release of Fourth Quarter and Full Year Fiscal 2024 Financial Results and Webcast of Investor Conference Call

Concentrix Reports Fourth Quarter and Fiscal Year 2024 Results

Concentrix Positioned as Highest Leader in Everest Group's B2B Sales Services PEAK Matrix® Assessment 2024

Introducing iX Hello™2.0: Smarter multi-modal customer facing assistants that are easy to create, customize and integrate across the enterprise

Comments

Concentrix

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga